Novel, potent, selective, and brain penetrant phosphodiesterase 10A inhibitors.
Geneste, H., Drescher, K., Jakob, C., Laplanche, L., Ochse, M., Torrent, M.(2019) Bioorg Med Chem Lett 29: 406-412
- PubMed: 30587449 
- DOI: https://doi.org/10.1016/j.bmcl.2018.12.029
- Primary Citation of Related Structures:  
6MSA, 6MSC - PubMed Abstract: 
Herein we report the discovery of a novel series of phosphodiesterase 10A inhibitors. Optimization of a HTS hit (17) resulted in potent, selective, and brain penetrant 23 and 26; both exhibited much lower clearance in vivo and decreased volume of distribution (rat PK) and have thus the potential to inhibit the PDE10A target in vivo at a lower efficacious dose than the reference compound WEB-3.
Organizational Affiliation: 
AbbVie Deutschland GmbH & Co. KG, Neuroscience Research, D-67008 Ludwigshafen, Germany. Electronic address: herve.geneste@abbvie.com.